GBS Inc. (NYSE:GBS – Get Free Report) rose 0.9% on Thursday . The stock traded as high as $2.28 and last traded at $2.20. Approximately 52,371 shares changed hands during trading, a decline of 95% from the average daily volume of 955,325 shares. The stock had previously closed at $2.18.
GBS Stock Performance
The stock has a fifty day simple moving average of $1.86 and a two-hundred day simple moving average of $1.65. The stock has a market cap of $31.57 million, a price-to-earnings ratio of -3.79 and a beta of 1.32.
GBS Company Profile
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
Recommended Stories
- Five stocks we like better than GBS
- Stock Dividend Cuts Happen Are You Ready?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What is a Stock Market Index and How Do You Use Them?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Are Dividend Contenders? Investing in Dividend Contenders
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
